Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment-Reference-Cited by-同舟云学术

Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment

Published:2015-07-14 Issue:5 Volume:37 Page:475-487
ISSN:1863-2297
Container-title:Seminars in Immunopathology
language:en
Short-container-title:Semin Immunopathol

Author:

Affandi Alsya J.,Radstake Timothy R. D. J.,Marut Wioleta

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00281-015-0506-4/fulltext.html

Reference143 articles.

1. Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989–2003. doi: 10.1056/NEJMra0806188

2. Masi AT (1988) Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 15:894–898

3. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35:35–42. doi: 10.1016/j.semarthrit.2005.03.005

4. Walker JG, Fritzler MJ (2007) Update on autoantibodies in systemic sclerosis. Curr Opin Rheumatol 19:580–591. doi: 10.1097/BOR.0b013e3282e7d8f9

5. Graf SW, Hakendorf P, Lester S et al (2012) South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. Int J Rheum Dis 15:102–109. doi: 10.1111/j.1756-185X.2011.01688.x

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis;Frontiers in Immunology;2024-05-10

2. MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling;Journal of Translational Medicine;2024-04-01

3. Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis;Journal of Inflammation Research;2023-10

4. Chromosome Segregation Defects in Scleroderma;Systemic Sclerosis - Recent Advances and New Perspectives [Working Title];2023-09-29

5. Could fecal calprotectin serve as an indicator of gastrointestinal (GI) complications in individuals with systemic sclerosis?;2023-09-01